Prince Charles Hospital
Prince Charles Hospital
Chermside, Queensland, Australia7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-10-01 | NCT06424288 | |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Nutritional and Metabolic Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, type 2 diabetes mellitus, vascular disorder | Recruiting | Phase 3 | 2026-09-30 | NCT07064473 | |
| ROADMAP Clinical Trial | Large Joint Prosthetic Joint Infections; Prosthetic Joint Infections of Hip; Prosthetic Joint Infections of Knee | Recruiting | Phase 4 | 2026-07-27 | NCT06771050 | |
| The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not applicable | 2026-07-21 | NCT04204915 | |
| RESPONDER-HF Trial | cardiovascular disorder, diastolic heart failure, heart disorder, heart failure | Active, not recruiting | Not applicable | 2026-03-18 | NCT05425459 | |
| The EXCEL Registry of Patients Requiring ECMO | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute respiratory failure, cardiac arrest, cardiovascular disorder, heart disorder | Recruiting | Not stated | 2023-09-15 | NCT03793257 | |
| Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy | Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Phase 3 | 2022-12-08 | NCT04083339 |